Search results
Results from the WOW.Com Content Network
Myocarditis after receiving a Covid vaccine is rare. Pfizer and Moderna are researching possible long-term risks for those who recovered from heart problems after vaccination.
As of June 11, more than 1,200 cases of myocarditis or pericarditis have been reported to the U.S. Vaccine Adverse Event Reporting System (VAERS), out of about 300 million mRNA vaccine doses ...
[49] [50] Additional pneumococcal vaccine research is taking place to find a vaccine that offers broad protection against pneumococcal disease. [51] As of 2017, pneumonia vaccines target up to 23 forms of the bacterium that cause pneumonia with a new version under development covering 72 strains of the bacterium. [52] [needs update]
Prevnar vaccine. Prevnar 20 (PCV20) is the third version of a vaccine produced by the Wyeth subsidiary of Pfizer.In April 2023, the FDA approved Prevnar 20 for the prevention of invasive disease caused by the 20 different serotypes of S. pneumoniae contained in the vaccine (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F) for individuals 6 ...
Pneumococcal polysaccharide vaccine, sold under the brand name Pneumovax 23, is a pneumococcal vaccine that is used for the prevention of pneumococcal disease caused by the 23 serotypes of Streptococcus pneumoniae contained in the vaccine as capsular polysaccharides. [2] It is given by intramuscular or subcutaneous injection. [2]
The Centers for Disease Control and Prevention has said it is monitoring reports of myocarditis, an inflammation of the heart muscle, and pericarditis, an inflammation of the outer lining of the ...
The FDA and European Medicines Agency estimates the risk of myocarditis after the Covid-19 vaccine as 1 case per 100,000 of those who are vaccinated. [31] [32] The risk of myocarditis after Covid-19 vaccination was observed to be highest in males between 16–29 years of age, and after receiving the second dose of the mRNA Covid-19 vaccine.
Ever since the vaccines from Pfizer and Moderna were authorized in late 2020, anti-vaccination groups in the U.S. have blamed the shots for fatal heart problems in young athletes.